Search Results - "Thierry Gil"

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 by DE SANTIS, Maria, BELLMUNT, Joaquim, COLLETTE, Sandra, LORENT, Julie, DE WIT, Ronald, SYLVESTER, Richard, MEAD, Graham, MARTIJN KERST, J, LEAHY, Michael, MAROTO, Pablo, GIL, Thierry, MARREAUD, Sandrine, DAUGAARD, Gedske, SKONECZNA, Iwona

“…This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible…”
Get full text

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial by Tannock, Ian F, Prof, Fizazi, Karim, Prof, Ivanov, Sergey, MD, Karlsson, Camilla Thellenberg, MD, Fléchon, Aude, MD, Skoneczna, Iwona, MD, Orlandi, Francisco, MD, Gravis, Gwenaelle, MD, Matveev, Vsevolod, MD, Bavbek, Sevil, Prof, Gil, Thierry, MD, Viana, Luciano, MD, Arén, Osvaldo, MD, Karyakin, Oleg, Prof, Elliott, Tony, PhD, Birtle, Alison, MD, Magherini, Emmanuelle, MD, Hatteville, Laurence, MSc, Petrylak, Daniel, Prof, Tombal, Bertrand, Prof, Rosenthal, Mark, Prof

“…Summary Background Docetaxel plus prednisone is standard first-line chemotherapy for men with metastatic castrate-resistant prostate cancer. Aflibercept is a…”
Get full text

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients by Plouznikoff, Nicolas, Artigas, Carlos, Sideris, Spyridon, Martinez Chanza, Nieves, Gil, Thierry, Peltier, Alexandre, Flamen, Patrick

“…Objective To investigate the association between Prostate-Specific Membrane Antigen (PSMA) expression changes on positron emission tomography–computed…”
Get full text

Digital Implementation of Oscillatory Neural Network for Image Recognition Applications by Abernot, Madeleine, Gil, Thierry, Jiménez, Manuel, Núñez, Juan, Avellido, María J., Linares-Barranco, Bernabé, Gonos, Théophile, Hardelin, Tanguy, Todri-Sanial, Aida

“…Computing paradigm based on von Neuman architectures cannot keep up with the ever-increasing data growth (also called “data deluge gap”). This has resulted in…”
Get full text

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial) by Martinez Chanza, Nieves, Soukane, Louisa, Barthelemy, Philippe, Carnot, Aurélien, Gil, Thierry, Casert, Vinciane, Vanhaudenarde, Vincent, Sautois, Brieuc, Staudacher, Lionel, Van den Brande, Jan, Culine, Stephane, Seront, Emmanuel, Gizzi, Marco, Albisinni, Simone, Tricard, Thibault, Fantoni, Jean Christophe, Paesmans, Marianne, Caparica, Rafael, Roumeguere, Thierry, Awada, Ahmad

“…Cisplatin-based neoadjuvant chemotherapy (NAC) followed by surgery is the standard treatment for patients with non-metastatic muscle invasive bladder cancer…”
Get full text

A mixed-signal oscillatory neural network for scalable analog computations in phase domain by Delacour, Corentin, Carapezzi, Stefania, Boschetto, Gabriele, Abernot, Madeleine, Gil, Thierry, Azemard, Nadine, Todri-Sanial, Aida

“…Digital electronics based on von Neumann’s architecture is reaching its limits to solve large-scale problems essentially due to the memory fetching. Instead,…”
Get full text

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis by Dumont, Laura, Salaroli, Adriano, Dal Lago, Lissandra, Gil, Thierry, Pepersack, Thierry

“…We report the case of a 76-year-old man presenting with reactive haemophagocytic lymphohistiocytosis (rHLH) in the setting of disseminated prostate cancer…”
Get full text

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma by Gourari, Karim, Catherine, Julien, Garaud, Soizic, Kerger, Joseph, Lepida, Antonia, Georgala, Aspasia, Lebrun, Fabienne, Gomez Galdon, Maria, Gil, Thierry, Willard-Gallo, Karen, Langouo Fontsa, Mireille

“…Tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) significantly improve the outcomes of patients with advanced clear cell renal cell…”
Get full text

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer by SIDERIS, SPYRIDON, AOUN, FOUAD, ZANATY, MARC, MARTINEZ, NIEVES CHANZA, LATIFYAN, SOFIA, AWADA, AHMAD, GIL, THIERRY

“…The aim of the present study was to investigate the efficacy of paclitaxel following a first-line cisplatin regimen in patients with metastatic bladder cancer…”
Get full text

Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study by Gil, Thierry, Aoun, Fouad, Cabri, Patrick, Perrot, Valérie, van Velthoven, Roland

“…Background: Lower urinary tract symptoms (LUTSs) may develop in men with prostate cancer (PCa) and can impact quality of life (QoL). Gonadotropin-releasing…”
Get full text

A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer by Gil, Thierry, Aoun, Fouad, Cabri, Patrick, Maisonobe, Pascal, van Velthoven, Roland

“…Objectives: Few studies have assessed the effect of gonadotropin-releasing hormone (GnRH) agonists, such as triptorelin, on lower urinary tract symptoms (LUTS)…”
Get full text

Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program by Van Praet, Charles, M.D, Rottey, Sylvie, M.D., Ph.D, Van Hende, Fransien, M.D, Pelgrims, Gino, M.D, Demey, Wim, M.D, Van Aelst, Filip, M.D, Wynendaele, Wim, M.D, Gil, Thierry, M.D, Schatteman, Peter, M.D, Filleul, Bertrand, M.D, Schallier, Dennis, M.D., Ph.D, Machiels, Jean-Pascal, M.D., Ph.D, Schrijvers, Dirk, M.D, Everaert, Els, M.D, D’Hondt, Lionel, M.D, Werbrouck, Patrick, M.D, Vermeij, Joanna, M.D, Mebis, Jeroen, M.D, Clausse, Marylene, M.D, Rasschaert, Marika, M.D, Van Erps, Joanna, M.D, Verheezen, Jolanda, M.D, Van Haverbeke, Jan, M.D, Goeminne, Jean-Charles, M.D, Lumen, Nicolaas, M.D., Ph.D

“…Abstract Background Abiraterone acetate (AA) is licensed for treating metastatic castration-resistant prostate cancer (mCRPC). Real-world data on oncological…”
Get full text

Molecular targeted therapies in breast cancer: Where are we now? by Widakowich, Christian, de Azambuja, Evandro, Gil, Thierry, Cardoso, Fatima, Dinh, Phuong, Awada, Ahmad, Piccart-Gebhart, Martine

“…Targeted therapies, in cancer treatment, represent a new generation of drugs that interfere with specific molecular targets (typically proteins) having…”
Get full text

A Mobile Computing Framework for Pervasive Adaptive Platforms by Brousse, Olivier, Guillot, Jérémie, Sassatelli, Gilles, Gil, Thierry, Grize, François, Robert, Michel

“…Ubiquitous computing is now the new computing trend, such systems that interact with their environment require self-adaptability. Bioinspiration is a natural…”
Get full text

68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy by Shagera, Qaid Ahmed, Artigas, Carlos, Karfis, Ioannis, Critchi, Gabriela, Chanza, Nieves Martinez, Sideris, Spyridon, Peltier, Alexandre, Paesmans, Marianne, Gil, Thierry, Flamen, Patrick

“…We aimed to evaluate the role of PET targeting the prostate-specific membrane antigen (PSMA) for response assessment in metastatic prostate cancer (PCa)…”
Get full text

Building an “Escape Portal” with Tethers Fixed in Asteroids by Prado, Antonio F. B. A., Gomes, Vivian Martins, Chanut, Thierry Gregory Gil

“…The main idea of this paper is to propose the construction of an “Escape Portal” to send a spacecraft to the exterior planets, or even to make it escape from…”
Get full text

COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab by Artigas, Carlos, Lemort, Marc, Mestrez, Fabienne, Gil, Thierry, Flamen, Patrick

“…ABSTRACTWithin a few months, coronavirus disease 2019 (COVID-19) has become a pandemic with more than 2 million patients infected and a high mortality rate…”
Get full text

Clinical impact of 68Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach by Albisinni, Simone, Artigas, Carlos, Aoun, Fouad, Biaou, Ibrahim, Grosman, Julien, Gil, Thierry, Hawaux, Eric, Limani, Ksenija, Otte, Francois‐Xavier, Peltier, Alexandre, Sideris, Spyridon, Sirtaine, Nicolas, Flamen, Patrick, Velthoven, Roland

“…Objective To assess the impact of a novel molecular imaging technique, 68Ga‐(HBED‐CC)‐prostate‐specific membrane antigen (PSMA) positron emission…”
Get full text

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours by Schöffski, Patrick, Awada, Ahmad, Dumez, Herlinde, Gil, Thierry, Bartholomeus, Sylvie, Wolter, Pascal, Taton, Martine, Fritsch, Holger, Glomb, Patricia, Munzert, Gerd

“…Abstract Background Volasertib (BI 6727) is a potent and selective cell-cycle kinase inhibitor that induces mitotic arrest and apoptosis by targeting Polo-like…”
Get full text

How Frequency Injection Locking Can Train Oscillatory Neural Networks to Compute in Phase by Todri-Sanial, Aida, Carapezzi, Stefania, Delacour, Corentin, Abernot, Madeleine, Gil, Thierry, Corti, Elisabetta, Karg, Siegfried F., Nunez, Juan, Jimenez, Manuel, Avedillo, Maria J., Linares-Barranco, Bernabe

“…Brain-inspired computing employs devices and architectures that emulate biological functions for more adaptive and energy-efficient systems. Oscillatory neural…”
Get full text